Chicago Trust’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$965K Buy
1,925
+309
+19% +$148K 0.14% 150
2026
Q1
$794K Sell
1,616
-286
-15% -$155K 0.13% 164
2025
Q4
$1.1M Buy
1,902
+45
+2% +$25.4K 0.17% 107
2025
Q3
$901K Sell
1,857
-59
-3% -$27.5K 0.13% 148
2025
Q2
$777K Buy
1,916
+655
+52% +$274K 0.11% 165
2025
Q1
$627K Sell
1,261
-299
-19% -$162K 0.11% 169
2024
Q4
$812K Sell
1,560
-161
-9% -$88.5K 0.14% 142
2024
Q3
$1.06M Buy
1,721
+64
+4% +$37.9K 0.18% 119
2024
Q2
$916K Sell
1,657
-86
-5% -$49.3K 0.19% 113
2024
Q1
$1.01M Sell
1,743
-197
-10% -$111K 0.21% 108
2023
Q4
$1.03M Sell
1,940
-279
-13% -$135K 0.23% 105
2023
Q3
$1.12M Sell
2,219
-207
-9% -$110K 0.28% 93
2023
Q2
$1.27M Sell
2,426
-56
-2% -$30.2K 0.3% 85
2023
Q1
$1.43M Sell
2,482
-35
-1% -$19.7K 0.36% 76
2022
Q4
$1.39M Sell
2,517
-263
-9% -$139K 0.35% 75
2022
Q3
$1.41M Sell
2,780
-65
-2% -$36.4K 0.37% 71
2022
Q2
$1.55M Sell
2,845
-327
-10% -$180K 0.39% 70
2022
Q1
$1.87M Sell
3,172
-845
-21% -$485K 0.4% 68
2021
Q4
$2.68M Sell
4,017
-200
-5% -$125K 0.53% 47
2021
Q3
$2.41M Buy
4,217
+380
+10% +$209K 0.53% 49
2021
Q2
$1.94M Buy
3,837
+1,253
+48% +$591K 0.46% 64
2021
Q1
$1.18M Sell
2,584
-530
-17% -$253K 0.4% 69
2020
Q4
$1.45M Buy
3,114
+57
+2% +$26.7K 0.5% 58
2020
Q3
$1.35M Buy
3,057
+100
+3% +$41.3K 0.56% 53
2020
Q2
$1.07M Buy
2,957
+197
+7% +$66K 0.47% 60
2020
Q1
$782K Sell
2,760
-316
-10% -$99.6K 0.4% 72
2019
Q4
$1M Hold
3,076
0.41% 66
2019
Q3
$896K Hold
3,076
0.38% 77
2019
Q2
$904 Buy
3,076
+200
+7% +$55.1K 0.39% 76
2019
Q1
$787 Hold
2,876
0.34% 77
2018
Q4
$644 Sell
2,876
-20
-0.7% -$4.69K 0.31% 89
2018
Q3
$707K Sell
2,896
-50
-2% -$11.5K 0.28% 88
2018
Q2
$610K Sell
2,946
-1
-0% -$212 0.26% 91
2018
Q1
$609K Sell
2,947
-886
-23% -$186K 0.26% 91
2017
Q4
$728K Sell
3,833
-19
-0.5% -$3.64K 0.29% 85
2017
Q3
$729 Hold
3,852
0.31% 85
2017
Q2
$672 Hold
3,852
0.3% 82
2017
Q1
$591 Sell
3,852
-2,425
-39% -$371K 0.26% 95
2016
Q4
$886K Sell
6,277
-1,350
-18% -$199K 0.38% 74
2016
Q3
$1.21M Sell
7,627
-150
-2% -$23.1K 0.53% 68
2016
Q2
$1.15M Sell
7,777
-20
-0.3% -$2.95K 0.47% 74
2016
Q1
$1.1M Sell
7,797
-475
-6% -$63.7K 0.46% 75
2015
Q4
$1.17M Hold
8,272
0.46% 76
2015
Q3
$1.01M Hold
8,272
0.39% 82
2015
Q2
$1.07M Hold
8,272
0.38% 81
2015
Q1
$1.11M Buy
+8,272
New +$1.07M 0.38% 81

Other funds holding TMO

Chicago Trust's TMO Position: Q2 2026 in Review

Chicago Trust increased its Thermo Fisher Scientific (TMO) stake by 19% in Q2 2026, buying an estimated $148K and bringing the position to 1,925 shares worth $965K. The position accounts for 0.14% of the portfolio, ranked #150.

Chicago Trust first reported a position in TMO in Q1 2015 and has held it in 46 quarters since. The position peaked at $2.68M in Q4 2021. 510 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Chicago Trust held 1,925 shares of Thermo Fisher Scientific worth $965K as of Q2 2026.
  • Chicago Trust bought 309 Thermo Fisher Scientific shares in Q2 2026, an estimated $148K.
  • Thermo Fisher Scientific made up 0.14% of Chicago Trust's portfolio in Q2 2026, its #150 holding.
  • Chicago Trust first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 46 quarters since.
  • Chicago Trust's Thermo Fisher Scientific position peaked at $2.68M in Q4 2021.
  • 510 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.